Atrás
Rango del Día
$11.12
$11.63
Rango de 52 Semanas
$10.75
$32.76
Volumen
1,549,422
Promedio 50D / 200D
$13.24
/
$21.38
Cierre Anterior
$11.80
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -11.6 | 0.3 |
| P/B | 2.6 | 2.9 |
| ROE % | -22.7 | 3.7 |
| Net Margin % | -13.9 | 3.8 |
| Rev Growth 5Y % | 29.6 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$27.50
+143.8%
Low: $22.00
High: $33.00
P/E Futuro
145.1
EPS Futuro
$0.08
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
480 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.16
$1.15 – $1.17
|
720 M | 1 |
| FY2029 |
$1.00
$0.99 – $1.01
|
660 M | 2 |
| FY2028 |
$0.79
$0.42 – $1.22
|
600 M | 10 |
Puntos Clave
Revenue grew 29.63% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Generating 8.29M in free cash flow
PEG of 0.47 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.80%
Capital efficient — spends only 5.74% of revenue on capex
Crecimiento
Revenue Growth (5Y)
29.63%
Revenue (1Y)17.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-22.67%
ROIC-15.42%
Net Margin-13.94%
Op. Margin-13.84%
Seguridad
Debt / Equity
0.07
Current Ratio1.78
Interest Coverage-24.75
Valoración
P/E Ratio
-11.62
P/B Ratio2.57
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.83% | Revenue Growth (3Y) | 22.25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29.63% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 419.81M | Net Income (TTM) | -58.53M |
| ROE | -22.67% | ROA | -15.07% |
| Gross Margin | 67.86% | Operating Margin | -13.84% |
| Net Margin | -13.94% | Free Cash Flow (TTM) | 8.29M |
| ROIC | -15.42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 1.78 |
| Interest Coverage | -24.75 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.62 | P/B Ratio | 2.57 |
| P/S Ratio | 1.62 | PEG Ratio | 0.47 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 680.04M | Enterprise Value | 613.62M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 419.81M | 356.30M | 280.91M | 213.23M | 148.68M |
| Net Income | -58.53M | -136.89M | -176.15M | -118.16M | -27.29M |
| EPS (Diluted) | -1.02 | -2.51 | -3.36 | -2.37 | -0.69 |
| Gross Profit | 284.88M | 232.29M | 171.64M | 131.85M | 96.29M |
| Operating Income | -58.10M | -136.48M | -176.55M | -116.82M | -25.67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 388.42M | 370.33M | 370.06M | 494.48M | 326.67M |
| Total Liabilities | 123.61M | 118.88M | 82.24M | 77.20M | 63.36M |
| Shareholders' Equity | 264.81M | 251.45M | 287.82M | 417.28M | 263.31M |
| Total Debt | 17.80M | 11.98M | 9.18M | 15.80M | 14.32M |
| Cash & Equivalents | 84.22M | 87.52M | 176.68M | 313.81M | 218.78M |
| Current Assets | 203.29M | 195.68M | 262.44M | 386.35M | 272.27M |
| Current Liabilities | 114.02M | 110.12M | 79.04M | 68.43M | 54.99M |